Special Issue "Study on Drug—Bee Venom Interactions"
Deadline for manuscript submissions: 31 January 2022.
Special Issues and Collections in MDPI journals
Thanks to previously published studies, the therapeutic effects of bee venom and its subcomponents, such as melittin and phospholipase A2, are relatively well known. To list a few examples, neuropathic pain, progressive muscle atrophy, idiopathic Parkinson’s disease, and cancers were all shown to be attenuated by bee venom administration. Furthermore, their mechanisms of action are also beginning to be clarified. However, in order for bee venom to be widely used against different types of diseases, its interaction with conventionally used drugs must be understood; thus far, the effects of their interactions have been poorly investigated.
Thus, this Special Issue of Toxins is devoted to understanding the interactions of bee venom and its subcomponents (i.e., apamin, melittin, phospholipase A2, etc.) with other drugs used to treat various diseases. We welcome all research focused on the combination effect of bee venom and other conventionally used drugs (i.e., anti-analgesic, anti-inflammatory, anti-cancerogenic drugs). Bee venom and drugs could be treated simultaneously or sequentially. In vivo and in vitro studies are all welcomed. Topics of interest include, but are not limited to, the following: bee venom; cancers; pain (neuropathic pain); immunology; and neuromodulation.
Prof. Dr. Woojin Kim
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bee venom
- combination treatment
- drug interactions
- mechanism of effects